PSA Blood Test Explained

A PSA blood test measures prostate-specific antigen in the blood. PSA is a protein made by cells of the prostate gland. It can be produced by normal prostate cells as well as prostate cancer cells. This is why PSA is useful, but also why it can be misunderstood.

A raised PSA does not automatically mean prostate cancer. The National Cancer Institute explains that both prostate cancer and benign conditions, especially benign prostatic hyperplasia and prostatitis, can cause PSA levels to rise.

This article explains what PSA is, why it may be tested, what can affect the result, and why PSA needs careful clinical interpretation.

What is PSA?

PSA stands for prostate-specific antigen. It is a protein produced by prostate gland cells. Small amounts of PSA can be found in the blood.

The prostate is a gland found in people assigned male at birth. It sits below the bladder and surrounds part of the urethra. PSA is linked with prostate tissue, which is why it can be used as a prostate-related blood marker.

The PSA test measures the amount of PSA in the blood. NCI states that PSA testing may be used to monitor prostate cancer progression, follow up prostate symptoms, or screen for prostate cancer in people without symptoms.

Why is PSA tested?

PSA may be tested for several reasons: follow-up of urinary or prostate symptoms, monitoring after prostate cancer treatment, screening discussions in selected people, follow-up of a previously raised PSA, risk assessment in people with higher prostate cancer risk, and monitoring known prostate disease.

Symptoms that may lead to PSA testing can include urinary changes, painful or frequent urination, blood in urine or semen, pelvic pain, or back pain. However, symptoms and PSA results need clinical interpretation. PSA is not a stand-alone answer.

PSA and screening

PSA screening is controversial because it can detect some prostate cancers early, but it can also lead to false positives, overdiagnosis, anxiety, unnecessary biopsies, and treatment of cancers that may never have caused harm.

NCI states that PSA testing is not recommended for routine prostate cancer screening in the general population and that many organisations advise people considering PSA screening to discuss risks and benefits with their doctors first. NCI also notes that some organisations recommend routine PSA testing from age 40 or 45 for people at higher risk, including Black men, people with inherited BRCA2 variants, and people with a father or brother who had prostate cancer.

The key message is that PSA is a useful but imperfect marker, and screening decisions depend on individual circumstances.

What is a normal PSA?

There is no single PSA number that perfectly separates normal from abnormal. NCI states that there is no single threshold that distinguishes a normal versus abnormal PSA result, partly because no specific PSA level means someone has prostate cancer. Higher PSA levels can increase the likelihood of prostate cancer being present, but they do not prove it.

Many sources historically discussed 4.0 ng/mL as a common threshold, but interpretation varies by age, medications, risk factors, prostate size, previous results, and clinical context. NCI notes that some doctors use higher cutoffs for older men and lower cutoffs for younger men.

This is why PSA should not be read as a simple pass/fail test.

What can raise PSA?

PSA can rise for reasons other than cancer. Possible causes include benign prostate enlargement, prostatitis or prostate inflammation, urinary infection, recent prostate biopsy, recent ejaculation, vigorous cycling or similar exercise, recent prostate examination or procedures, age-related prostate changes, prostate cancer, and laboratory and biological variation.

NCI states that prostate infection or inflammation, recent prostate biopsy, vigorous exercise such as cycling, and ejaculation can temporarily raise PSA. It also notes that people are often advised to wait until temporary factors resolve and avoid activities that may raise PSA for two days before testing.

Can medications lower PSA?

Yes. Some medications can lower PSA. NCI notes that drugs such as finasteride and dutasteride, used to treat benign prostatic hyperplasia, lower PSA levels.

This matters because a “lower” PSA result is not always straightforward if the person is taking medication that affects prostate tissue and PSA production.

What happens if PSA is raised?

A raised PSA may lead to repeat testing, observation, examination, imaging, urine or blood-based tests, or biopsy depending on the situation.

NCI explains that if a screening test shows an abnormal PSA in someone without symptoms, a doctor may recommend another PSA test in 6 to 8 weeks to confirm the finding. If PSA remains elevated, they may recommend continued observation, repeat PSA tests, digital rectal exams, or further testing such as MRI or other tests.

This repeat-testing approach shows why one PSA result is rarely the whole answer.

PSA after prostate cancer treatment

PSA can also be used after prostate cancer treatment. NCI explains that PSA is used after surgery or radiation therapy to monitor for recurrence. A rising PSA after treatment may be an early sign of recurrence, but a single elevated PSA does not always mean cancer has returned; doctors may repeat the test or look for a rising trend over time.

What sample is used?

PSA is measured using a blood sample, usually taken from a vein in the arm. The laboratory measures PSA concentration in serum or plasma depending on method and local practice. The result is usually reported in ng/mL, though units and reference comments vary by laboratory.

Why trend matters

PSA trend can be more useful than one isolated result. A stable PSA may mean something different from a PSA that is rising quickly. Previous results, age, prostate size, symptoms, infection history, and medications all help shape interpretation.

NCI notes that doctors may look for a trend of rising PSA over time rather than relying on a single elevated measurement.

Key takeaway

PSA is a prostate-related blood marker. It can be raised in prostate cancer, but also in benign enlargement, inflammation, infection, recent procedures, ejaculation, cycling, and other situations.

A raised PSA is not a diagnosis. It is a result that may need repeat testing, clinical review, risk assessment, imaging, or further investigation depending on context.

The best way to understand PSA is as a useful but imperfect prostate signal.

FAQ

Does a high PSA mean prostate cancer?
No. PSA can rise because of prostate cancer, but also because of benign enlargement, prostatitis, infection, exercise, ejaculation, or recent procedures.

What PSA level is abnormal?
There is no single threshold that perfectly separates normal from abnormal. NCI notes that 4.0 ng/mL is often considered abnormal, but cutoffs vary by age and context.

Why might PSA be repeated?
PSA can be temporarily raised. NCI says a repeat PSA after 6 to 8 weeks may be recommended to confirm an abnormal screening result.

Can medication affect PSA?
Yes. Medications such as finasteride and dutasteride can lower PSA levels.